Animportant aspect to consider in the multiple myeloma (MM) treatmentstrategy is the loss-of-function mutations in the TSC complex resultingin a genetic disorder, tuberous sclerosis complex (TSC), also knownas tuberous sclerosis. Here, TSC1 is linked to Miyoshi myopathy.